The metrics, or the truth?

In pharma launches, the numbers always look great… until they don’t. Everyone monitors the KPIs. But few notice the quiet signals that show launch is drifting, until it's too late. In this session, we expose the illusion of insight completeness: why your reporting feels thorough but hides the signals that matter most.

You’ll learn how market leaders avoid being blindsided by uncovering patterns before they show up in traditional reports. And you’ll see how teams that operate faster than the feedback loop are building a new kind of intelligence layer: one that makes your dashboard not just smarter, but allows you to hit the market earlier.

Key takeaways:

• Why most pharma KPIs are lagging indicators, and what to watch for instead
• How real-time signals (from DOLs, sentiment, stakeholder actions) expose unseen risks
• Where medical and commercial teams can collaborate around early warnings and unseen opportunities
• How to make ‘insight latency’ a thing of the past